BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26514120)

  • 1. Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment.
    Rubio IT; Esgueva-Colmenarejo A; Espinosa-Bravo M; Salazar JP; Miranda I; Peg V
    Ann Surg Oncol; 2016 Jan; 23(1):38-43. PubMed ID: 26514120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.
    Siso C; de Torres J; Esgueva-Colmenarejo A; Espinosa-Bravo M; Rus N; Cordoba O; Rodriguez R; Peg V; Rubio IT
    Ann Surg Oncol; 2018 Mar; 25(3):784-791. PubMed ID: 29197044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer.
    Ramos M; Díaz JC; Ramos T; Ruano R; Aparicio M; Sancho M; González-Orús JM
    Breast; 2013 Aug; 22(4):520-4. PubMed ID: 23110817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
    Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative ultrasound in conservative surgery for non-palpable breast cancer after neoadjuvant chemotherapy.
    Ramos M; Díez JC; Ramos T; Ruano R; Sancho M; González-Orús JM
    Int J Surg; 2014; 12(6):572-7. PubMed ID: 24735893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
    Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
    J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-guided lumpectomy for palpable breast cancers.
    Fisher CS; Mushawah FA; Cyr AE; Gao F; Margenthaler JA
    Ann Surg Oncol; 2011 Oct; 18(11):3198-203. PubMed ID: 21861232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning curves in intraoperative ultrasound guided surgery in breast cancer based on complete breast cancer excision and no need for second surgeries.
    Esgueva A; Rodríguez-Revuelto R; Espinosa-Bravo M; Salazar JP; Rubio IT
    Eur J Surg Oncol; 2019 Apr; 45(4):578-583. PubMed ID: 30737056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
    Chung A; Gangi A; Amersi F; Bose S; Zhang X; Giuliano A
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S422-7. PubMed ID: 26310280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas.
    Lovrics PJ; Goldsmith CH; Hodgson N; McCready D; Gohla G; Boylan C; Cornacchi S; Reedijk M
    Ann Surg Oncol; 2011 Nov; 18(12):3407-14. PubMed ID: 21533657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT).
    Volders JH; Haloua MH; Krekel NM; Negenborn VL; Kolk RH; Lopes Cardozo AM; Bosch AM; de Widt-Levert LM; van der Veen H; Rijna H; Taets van Amerongen AH; Jóźwiak K; Meijer S; van den Tol MP
    Eur J Surg Oncol; 2017 Apr; 43(4):649-657. PubMed ID: 27916314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection margins in ultrasound-guided breast-conserving surgery.
    Olsha O; Shemesh D; Carmon M; Sibirsky O; Abu Dalo R; Rivkin L; Ashkenazi I
    Ann Surg Oncol; 2011 Feb; 18(2):447-52. PubMed ID: 20734147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.
    Straver ME; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Wesseling J; Russell NS; Oldenburg HS; Antonini N; Vrancken Peeters MT
    Ann Surg Oncol; 2010 Sep; 17(9):2411-8. PubMed ID: 20373039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of intra-operative margin management techniques in breast-conserving surgery: a standardised approach reduces the likelihood of residual disease without increasing operative time.
    Bolger JC; Solon JG; Khan SA; Hill AD; Power CP
    Breast Cancer; 2015 May; 22(3):262-8. PubMed ID: 23649303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
    Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M
    Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
    Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
    Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
    Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
    Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.